Morino S, Teraoka Y, Doi M, Ishida T, Ueda H, Uesugi S
Department of Physical Chemistry, Osaka University of Pharmaceutical Sciences, Japan.
Biol Pharm Bull. 1995 Feb;18(2):372-6. doi: 10.1248/bpb.18.372.
In order to obtain the active form of recombinant human initiation factor (eIF) 4E effectively, an artificial synthetic gene was cloned into an expression vector (pMAL-p2) and the soluble expression was attempted in Escherichia coli under the control of a tac promoter. Two expression systems were finally constructed as a fusion protein with maltose-binding protein, which contain a recognition sequence for the site specific protease alpha-thrombin and factor Xa, respectively. Most of the fusion protein was induced as a soluble form. The soluble human eIF-4E digested from the fusion protein showed binding specificity for the m7GTP affinity column.
为了有效获得重组人起始因子(eIF)4E的活性形式,将人工合成基因克隆到表达载体(pMAL-p2)中,并尝试在tac启动子控制下在大肠杆菌中进行可溶性表达。最终构建了两个作为与麦芽糖结合蛋白融合蛋白的表达系统,它们分别包含位点特异性蛋白酶α-凝血酶和因子Xa的识别序列。大多数融合蛋白以可溶性形式被诱导表达。从融合蛋白中消化得到的可溶性人eIF-4E对m7GTP亲和柱表现出结合特异性。